HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressional Split Looms Over Including Retroactive Reach In FTC Monetary Relief Authority

Executive Summary

Lawmakers disagree whether legislation to amend an FTC regulation to grant the commission authority to pursue monetary remedies should be retroactive, which would impact approximately 75 pending federal court cases alleging violations.

You may also be interested in...



US FTC Section 13(b) Revamp Gains Traction With Senate ‘Fix’ In The Works

There is strong support for a bipartisan fix to discourage marketplace fraud and anticompetitive practices and enable consumer redress under the FTC Act. But Congress is distracted and deeply divided with different ideas about how extensive the FTC’s authorities should be under Section 13(b) of the FTC Act.

Supplement Direct Seller Pays In Settlement Filed Before US FTC’s Monetary Relief Authority Axed

AdvoCare return money lost in its pyramid scheme requiring distributors to buy thousands of dollars of products to be eligible for cash bonuses, other rewards but compensated distributors for attracting additional recruits, not for sales to customers.

FTC ‘Dark Patterns' Enforcement Policy Darkens Public Input On Rule, Commissioner Wilson Argues

Wilson’s dissenting statement isn’t first time she's disagreed with Democrat majority on the five-seat commission after four years of a Republican majority. Her statement made clear her argument the commission has over-stepped its authorities more than once.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel